Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial. (Record no. 24017216)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02605 a2200733 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516223400.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201412s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1474-5488 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S1470-2045(14)70314-6 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Taal, Walter |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20141215 |
| 245 00 - TITLE STATEMENT | |
| Title | Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Lancet. Oncology |
| Date of publication, distribution, etc. | Aug 2014 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 943-53 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Administration, Oral |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bevacizumab |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Brain Neoplasms |
| General subdivision | mortality |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Combinations |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Therapy, Combination |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Follow-Up Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Glioblastoma |
| General subdivision | mortality |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Infusions, Intravenous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lomustine |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Maximum Tolerated Dose |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Invasiveness |
| General subdivision | pathology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Recurrence, Local |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Staging |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Analysis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Oosterkamp, Hendrika M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Walenkamp, Annemiek M E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dubbink, Hendrikus J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Beerepoot, Laurens V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hanse, Monique C J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Buter, Jan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Honkoop, Aafke H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Boerman, Dolf |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | de Vos, Filip Y F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dinjens, Winand N M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Enting, Roelien H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Taphoorn, Martin J B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van den Berkmortel, Franchette W P J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jansen, Rob L H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brandsma, Dieta |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bromberg, Jacoline E C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Heuvel, Irene |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vernhout, René M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van der Holt, Bronno |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van den Bent, Martin J |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Lancet. Oncology |
| Related parts | vol. 15 |
| -- | no. 9 |
| -- | p. 943-53 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S1470-2045(14)70314-6">https://doi.org/10.1016/S1470-2045(14)70314-6</a> |
| Public note | Available from publisher's website |
No items available.